Part IV. Neuroimaging in dementing disorders

Disease-a-Month

Volumn 46, Issue 10, 2000, Pages 707-724

  DeCarli, Charles ^a,b  

^a Alzheimer's Disease Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; BRAIN ATROPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; LEWY BODY; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEMENTIA; IMAGE PROCESSING; METHODOLOGY; PRACTICE GUIDELINE;

DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033764956     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-5029(00)90031-2     Document Type: Article

References (66)

1. Factors affecting the measurement of size and CT number in computed tomography
2. Basic principals of magnetic resonance imaging
3. Correction of intensity nonuniformity in MR images of any orientation
4. Evaluation of the brain by positron emission tomography
5. Quantification and analysis of positron emission tomography metabolic data
6. Positron emission tomography: Principles and quantitation
7. Quantitation in positron emission computed tomography: 1. Effect of object size
8. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system
9. Coupling between cerebral blood flow, oxygen consumption, and glucose utilization: Its study with positron tomography
10. The concept of coupling blood flow to brain function: Revision required?
11. Receptor imaging by PET and SPECT: Focus on the opiate receptor
12. Functional neuroimaging with single photon emission computed tomography (SPECT)
13. Functional brain imaging with SPECT in normal aging and dementia: Methodological, pathophysiological, and diagnostc aspects
14. Brain perfusion SPECT using an annular single crystal camera: Initial clinical experience
15. Quantitation of rCBF by 99mTc-hexamethylpropyleneamine oxime single photon emission computed tomography combined with 133Xe CBF
16. Critical analysis of the use of computer assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type
17. The ventricular-brain ratio on computed tomography scans: Validity and proper use
18. Evaluation of dementia: A systematic study of the usefulness of the American Academy of Neurology's Practice Parameters
19. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia
20. CT diagnostic features of Alzheimer disease: Importance of the choroidal/hippocampal fissure complex
21. The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation
22. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography
23. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
24. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
25. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease
26. Prediction of AD with MRI-base hippocampal volume in mild cognitive impairment
27. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia
28. Qualitative assessment of cerebral atrophy on MRI: Inter- and intra-observer reproducibility in dementia and normal aging
29. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population
30. Abnormal brain glucose metabolism in Alzheimer's disease as measured by positron emission tomography
31. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type
32. Clinical value of neuroimaging in the diagnosis of dementia: Sensitivity and specificity of regional cerebral metabolic and other parameters for early identification of Alzheimer's disease
33. Differential diagnosis of Alzheimer's disease with PET
34. Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients
35. Sensitivity, specificity and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias
36. Diagnosing Alzheimer's disease in elderly, mildly demented patients: The impact of routine single photon emission computed tomography
37. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: A population based study
38. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?
39. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Work Group
40. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
41. The effect of white matter hyperintensity volume on brain structure, cognitive performance and cerebral metabolism in 51 healthy adults
42. Predictors of brain morphology among the men of the NHLBI Twin Study
43. Comparison of positron emission tomography, cognition and brain volume in Alzheimer's disease with and without severe white matter abnormalities
44. The aging brain and neurodegenerative disorders
45. Medical temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study
46. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes
47. Magnetic resonance imaging of corticobasal degeneration
48. MRI in autonomic failure
49. Progressive supranuclear palsy: MRI and pathological findings
50. Neuroimaging in the diagnosis of frontotemporal dementia
51. Imaging in primary progressive aphasia
52. Cerebral glucose metabolism in patients with frontotemporal dementia
53. Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease
54. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type
55. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease
56. Preclinical prediction of Alzheimer's disease using SPECT
57. Detection, visualization and animation of abnormal anatomic structure with a deformable probabilistic brain atlas based on random vector field transformations
58. Brain atrophy progression measured from registered serial MRI: Validation and application to Alzheimer's disease
59. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease
60. Correlation between rates of brain atrophy and cognitive decline in AD
61. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E
62. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease
63. Inhibition of N-acetylaspartate production: Implication for 1H MRS studies in vivo
64. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: A 1H MRS study
65. PET imaging of tangles and plaques in Alzheimer disease